$OPCH
Option Care Health, Inc.

2013 Q1 Form 10-Q Financial Statement

#000101473913000004 Filed on May 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $181.1M $155.6M
YoY Change 16.38% 18.95%
Cost Of Revenue $125.1M $102.1M
YoY Change 22.56% 28.47%
Gross Profit $55.99M $53.52M
YoY Change 4.61% 4.23%
Gross Profit Margin 30.91% 34.39%
Selling, General & Admin $50.10M $48.00M
YoY Change 4.38% 8.84%
% of Gross Profit 89.49% 89.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.418M $1.931M
YoY Change 25.22% 44.86%
% of Gross Profit 4.32% 3.61%
Operating Expenses $52.20M $48.90M
YoY Change 6.75% 8.91%
Operating Profit -$2.187M $4.044M
YoY Change -154.08% -21.93%
Interest Expense $6.478M $6.569M
YoY Change -1.39% -0.65%
% of Operating Profit 162.44%
Other Income/Expense, Net
YoY Change
Pretax Income -$8.538M -$2.525M
YoY Change 238.14% 76.33%
Income Tax -$224.0K -$502.0K
% Of Pretax Income
Net Earnings -$8.128M -$2.703M
YoY Change 200.7% -191.91%
Net Earnings / Revenue -4.49% -1.74%
Basic Earnings Per Share -$0.14 -$0.05
Diluted Earnings Per Share -$0.14 -$0.05
COMMON SHARES
Basic Shares Outstanding 57.05M shares 55.31M shares
Diluted Shares Outstanding 57.05M shares 55.31M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $9.100M $38.60M
YoY Change -76.42% 121.84%
Inventory $22.82M $13.78M
Prepaid Expenses
Receivables $158.1M $242.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $190.0M $294.6M
YoY Change -35.49% 11.28%
LONG-TERM ASSETS
Property, Plant & Equipment $27.77M $26.23M
YoY Change 5.86% 7.94%
Goodwill $414.2M $312.4M
YoY Change 32.6%
Intangibles $19.36M $17.45M
YoY Change 10.99%
Long-Term Investments $10.40M
YoY Change
Other Assets $1.385M $1.420M
YoY Change -2.46% -83.49%
Total Long-Term Assets $475.7M $379.5M
YoY Change 25.36% -1.64%
TOTAL ASSETS
Total Short-Term Assets $190.0M $294.6M
Total Long-Term Assets $475.7M $379.5M
Total Assets $665.7M $674.0M
YoY Change -1.23% 3.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.11M $84.74M
YoY Change -62.11% 8.37%
Accrued Expenses $49.20M $40.10M
YoY Change 22.69% -19.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $28.00M $64.05M
YoY Change -56.29% 22.01%
Total Short-Term Liabilities $133.2M $218.4M
YoY Change -39.02% 4.38%
LONG-TERM LIABILITIES
Long-Term Debt $225.4M $227.3M
YoY Change -0.84% 0.99%
Other Long-Term Liabilities $8.971M $3.681M
YoY Change 143.71% 26.93%
Total Long-Term Liabilities $8.971M $231.0M
YoY Change -96.12% 1.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $133.2M $218.4M
Total Long-Term Liabilities $8.971M $231.0M
Total Liabilities $378.2M $459.4M
YoY Change -17.66% 2.93%
SHAREHOLDERS EQUITY
Retained Earnings -$93.21M -$152.5M
YoY Change -38.87%
Common Stock $391.0M $377.6M
YoY Change 3.54%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.31M $10.46M
YoY Change -1.43%
Treasury Stock Shares 2.583M shares 2.638M shares
Shareholders Equity $287.5M $214.7M
YoY Change
Total Liabilities & Shareholders Equity $665.7M $674.0M
YoY Change -1.23% 3.62%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$8.128M -$2.703M
YoY Change 200.7% -191.91%
Depreciation, Depletion And Amortization $2.418M $1.931M
YoY Change 25.22% 44.86%
Cash From Operating Activities -$12.85M $2.525M
YoY Change -608.83% -92.02%
INVESTING ACTIVITIES
Capital Expenditures -$3.600M -$1.500M
YoY Change 140.0% 66.67%
Acquisitions $72.33M $0.00
YoY Change
Other Investing Activities -$73.30M -$200.0K
YoY Change 36550.0% -89.47%
Cash From Investing Activities -$76.88M -$1.741M
YoY Change 4315.85% -37.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $27.63M -$784.0K
YoY Change -3623.85% -97.28%
NET CHANGE
Cash From Operating Activities -$12.85M $2.525M
Cash From Investing Activities -$76.88M -$1.741M
Cash From Financing Activities $27.63M -$784.0K
Net Change In Cash -$62.10M $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$12.85M $2.525M
Capital Expenditures -$3.600M -$1.500M
Free Cash Flow -$9.248M $4.025M
YoY Change -329.76% -87.64%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
32108000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34438000 USD
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
356000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33365000 USD
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35505000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
388798000 USD
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
390983000 USD
CY2012Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
879000 USD
CY2013Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2082000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21482000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
22212000 USD
CY2012Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
284000 USD
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
879000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2082000 USD
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6900000 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6500000 shares
CY2012Q4 us-gaap Assets
Assets
642376000 USD
CY2013Q1 us-gaap Assets
Assets
665714000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
235427000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
190027000 USD
CY2012Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
46708000 USD
CY2012Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
30859000 USD
CY2012Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
2900000 USD
CY2013Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
1311000 USD
CY2013Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
625000 USD
CY2013Q1 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
185000 USD
CY2013Q1 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0 USD
CY2013Q1 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
23000 USD
CY2013Q1 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
192000 USD
CY2013Q1 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
225000 USD
CY2013Q1 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2012Q1 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
700000 USD
CY2013Q1 us-gaap Capitalized Computer Software Amortization
CapitalizedComputerSoftwareAmortization
400000 USD
CY2013Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
9939000 USD
CY2012Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
9939000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62101000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-62101000 USD
CY2013Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 USD
CY2012Q1 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
2741000 USD
CY2013Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-658000 USD
CY2012Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
6401000 USD
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
10
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59695646 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59600713 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57113126 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57026957 shares
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2013Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
7178000 USD
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4315000 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
135834000 USD
CY2012Q1 us-gaap Cost Of Revenue
CostOfRevenue
102111000 USD
CY2013Q1 us-gaap Cost Of Services
CostOfServices
30301000 USD
CY2012Q1 us-gaap Cost Of Services
CostOfServices
29785000 USD
CY2012Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-29000 USD
CY2013Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-519000 USD
CY2013Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-399000 USD
CY2012Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-202000 USD
CY2013Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
120000 USD
CY2012Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-173000 USD
CY2012Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-262000 USD
CY2013Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
399000 USD
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2877000 USD
CY2013Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2522000 USD
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
457000 USD
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-300000 USD
CY2012Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-38000 USD
CY2013Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
58000 USD
CY2013Q1 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
10748000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
10291000 USD
CY2012Q1 us-gaap Depreciation
Depreciation
1931000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
2459000 USD
CY2013Q1 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
101600000 USD
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Goodwill
DisposalGroupIncludingDiscontinuedOperationGoodwill
11754000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
-68000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
22960000 USD
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Net
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNet
2503000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
700000 USD
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Inventory
DisposalGroupIncludingDiscontinuedOperationInventory
30560000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
22916000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
619000 USD
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment Net
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet
1592000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
338103000 USD
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
-20000 USD
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2012Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9854000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11936000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
939000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2664000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11900000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15900000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2046000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3964000 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3219000 USD
CY2013Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3539000 USD
CY2012Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-23000 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-13000 USD
CY2013Q1 us-gaap Goodwill
Goodwill
414234000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
350810000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
53522000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
63237000 USD
CY2012Q1 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
72326000 USD
CY2013Q1 us-gaap Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
105533000 USD
CY2013Q1 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
150024000 USD
CY2012Q1 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
106803000 USD
CY2013Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
49047000 USD
CY2012Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
48830000 USD
CY2013Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
199071000 USD
CY2012Q1 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
155633000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7470000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2023000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7412000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2525000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.13
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.04
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.13
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.04
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-658000 USD
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-680000 USD
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
58000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-502000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2818000 USD
CY2012Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
430000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2594000 USD
CY2012Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-884000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
236000 USD
CY2012Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
0 USD
CY2012Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
49000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
157000 USD
CY2013Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-47000 USD
CY2012Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-103000 USD
CY2012Q1 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
6000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-512000 USD
CY2013Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-6000 USD
CY2012Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
197000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
5587000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2822000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
6569000 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
6478000 USD
CY2013Q1 us-gaap Interest Paid Net
InterestPaidNet
322000 USD
CY2012Q1 us-gaap Interest Paid Net
InterestPaidNet
1241000 USD
CY2013Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
11575000 USD
CY2012Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
5803000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
34034000 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
22819000 USD
CY2012Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
10042000 USD
CY2013Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
10415000 USD
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1800000 USD
CY2012Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1500000 USD
CY2013Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-4445000 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
7164000 USD
CY2013Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
8383000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
348967000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
378248000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
642376000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
665714000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-457000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
300000 USD
CY2012Q1 us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
-6598000 USD
CY2013Q1 us-gaap Increase Decrease In Future Policy Benefit Reserves
IncreaseDecreaseInFuturePolicyBenefitReserves
187000 USD
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4215000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13199000 USD
CY2012Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
4557000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2487000 USD
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4238000 USD
CY2013Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
16526000 USD
CY2012Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
16761000 USD
CY2012Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
15400000 USD
CY2013Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
15400000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17446000 USD
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19364000 USD
CY2012Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17446000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
108269000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
133157000 USD
CY2013Q1 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
27053000 USD
CY2012 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
800000 USD
CY2013Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
225372000 USD
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
225426000 USD
CY2013Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
27992000 USD
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
953000 USD
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
27700000 USD
CY2013Q1 us-gaap Loss Contingency Accrual Carrying Value Provision
LossContingencyAccrualCarryingValueProvision
2300000 USD
CY2013Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
3500000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2053000 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1385000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12848000 USD
CY2012Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6582000 USD
CY2013Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
7916000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
5481000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
6535000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
5024000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27627000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-784000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1741000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76880000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4482000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-76880000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2525000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3876000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12190000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-8128000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-2703000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4044000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-934000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
30809000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
5436000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
3815000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4518000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4981000 USD
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8971000 USD
CY2012Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
44575000 USD
CY2013Q1 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
52791000 USD
CY2012Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
1547000 USD
CY2013Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
3655000 USD
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
72325000 USD
CY2012Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2012Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0 USD
CY2013Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
900000 USD
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9081000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10189000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1324000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
642000 USD
CY2012Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
481151000 USD
CY2013Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
214145000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57086000 USD
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63272000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23721000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27767000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3397000 USD
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3465000 USD
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
129103000 USD
CY2013Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
158127000 USD
CY2013Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
187092000 USD
CY2012Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
483224000 USD
CY2013Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
68000 USD
CY2012Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
35000 USD
CY2013Q1 us-gaap Restructuring Charges
RestructuringCharges
1278000 USD
CY2012Q1 us-gaap Restructuring Charges
RestructuringCharges
387000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85084000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93212000 USD
CY2012Q1 us-gaap Revenues
Revenues
155633000 USD
CY2013Q1 us-gaap Revenues
Revenues
199071000 USD
CY2013Q1 us-gaap Senior Notes
SeniorNotes
225000000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1973000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
966000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
293409000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
287466000 USD
CY2012Q4 us-gaap Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves
SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves
7411000 USD
CY2013Q1 us-gaap Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves
SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves
7599000 USD
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2582520 shares
CY2013Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2582520 shares
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
10311000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10311000 USD
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2012Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55307000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57047000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55307000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57047000 shares
CY2013Q1 bios Accounts Receivable And Working Capital Liabilities Relating To Operations Subject To Pharmacy Services Asset Sale
AccountsReceivableAndWorkingCapitalLiabilitiesRelatingToOperationsSubjectToPharmacyServicesAssetSale
1300000 USD
CY2012Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
41491000 USD
CY2013Q1 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
37580000 USD
CY2012Q1 bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
172000 USD
CY2013Q1 bios Acquisition And Integration Expenses
AcquisitionAndIntegrationExpenses
4623000 USD
CY2012Q1 bios Adjusted Ebitda
AdjustedEbitda
14961000 USD
CY2013Q1 bios Adjusted Ebitda
AdjustedEbitda
19397000 USD
CY2013Q1 bios Amortization Expense Year2 And Beyond
AmortizationExpenseYear2AndBeyond
361000 USD
CY2013Q1 bios Amount Company May Be Required To Refund Related Directly Or Indirectly To Buyers Retention Of Certain Business After Closing
AmountCompanyMayBeRequiredToRefundRelatedDirectlyOrIndirectlyToBuyersRetentionOfCertainBusinessAfterClosing
6400000 USD
CY2012Q1 bios Amount Company Received As Result Of Agreement Which Provided That Bioscrip Ceased To Be Sole Fulfillment Pharmacy For Customers Who Came Through Drugstore Com Website
AmountCompanyReceivedAsResultOfAgreementWhichProvidedThatBioscripCeasedToBeSoleFulfillmentPharmacyForCustomersWhoCameThroughDrugstoreComWebsite
3000000 USD
CY2012Q1 bios Amounts Due To Plan Sponsor
AmountsDueToPlanSponsor
874000 USD
CY2013Q1 bios Amounts Due To Plan Sponsor
AmountsDueToPlanSponsor
4140000 USD
CY2013Q1 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
16303000 USD
CY2012Q4 bios Amounts Due To Plan Sponsors
AmountsDueToPlanSponsors
18173000 USD
CY2012Q1 bios Antidilutive Warrants Excluded From Computation Of Earnings Per Share Amount
AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013Q1 bios Antidilutive Warrants Excluded From Computation Of Earnings Per Share Amount
AntidilutiveWarrantsExcludedFromComputationOfEarningsPerShareAmount
3400000 shares
CY2013Q1 bios Business Acquisition Purchase Price Adjustment Working Capital
BusinessAcquisitionPurchasePriceAdjustmentWorkingCapital
2300000 USD
CY2013Q1 bios Capital Lease Obligations Incurred To Acquire Property And Equipment
CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment
0 USD
CY2012Q1 bios Capital Lease Obligations Incurred To Acquire Property And Equipment
CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment
20000 USD
CY2013Q1 bios Cash Consideration Paid Dspharmacy
CashConsiderationPaidDspharmacy
0 USD
CY2012Q1 bios Intangible Assets Gross
IntangibleAssetsGross
27300000 USD
CY2013Q1 bios Intangible Assets Gross
IntangibleAssetsGross
31300000 USD
CY2013Q1 bios Long Term Debt And Capital Lease Obligations Total
LongTermDebtAndCapitalLeaseObligationsTotal
253364000 USD
CY2012Q1 bios Cash Consideration Paid Dspharmacy
CashConsiderationPaidDspharmacy
-2935000 USD
CY2012Q4 bios Computer And Office Equipment Gross
ComputerAndOfficeEquipmentGross
14443000 USD
CY2013Q1 bios Computer And Office Equipment Gross
ComputerAndOfficeEquipmentGross
14976000 USD
CY2012Q2 bios Contingent Consideration Period
ContingentConsiderationPeriod
P14M
CY2012 bios Disposal Group Including Discontinued Operation Proceeds
DisposalGroupIncludingDiscontinuedOperationProceeds
173800000 USD
CY2013Q1 bios Disposal Group Including Discontinued Operations Prepaid Expenses And Other Current Assets
DisposalGroupIncludingDiscontinuedOperationsPrepaidExpensesAndOtherCurrentAssets
43000 USD
CY2012Q4 bios Disposal Group Including Discontinued Operations Prepaid Expenses And Other Current Assets
DisposalGroupIncludingDiscontinuedOperationsPrepaidExpensesAndOtherCurrentAssets
134000 USD
CY2012Q2 bios Disposal Group Including Discontinued Operations Prepaid Expenses And Other Current Assets
DisposalGroupIncludingDiscontinuedOperationsPrepaidExpensesAndOtherCurrentAssets
299000 USD
CY2013Q1 bios Future Minimum Leases Due Thereafter
FutureMinimumLeasesDueThereafter
5024000 USD
CY2013Q1 bios Future Minimum Payments Due
FutureMinimumPaymentsDue
31434000 USD
CY2013Q1 bios Future Minimum Payments Due Current
FutureMinimumPaymentsDueCurrent
5621000 USD
CY2013Q1 bios Future Minimum Payments Due In Five Years
FutureMinimumPaymentsDueInFiveYears
3815000 USD
CY2013Q1 bios Future Minimum Payments Due In Four Years
FutureMinimumPaymentsDueInFourYears
4541000 USD
CY2013Q1 bios Future Minimum Payments Due In Three Years
FutureMinimumPaymentsDueInThreeYears
5673000 USD
CY2013Q1 bios Future Minimum Payments Due In Two Years
FutureMinimumPaymentsDueInTwoYears
6760000 USD
CY2012Q1 bios Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
0 USD
CY2013Q1 bios Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
0 USD
CY2012Q1 bios Indefinite Lived Intangible Assets Gross
IndefiniteLivedIntangibleAssetsGross
15400000 USD
CY2013Q1 bios Indefinite Lived Intangible Assets Gross
IndefiniteLivedIntangibleAssetsGross
15400000 USD
CY2012Q1 bios Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
9854000 USD
CY2013Q1 bios Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
11936000 USD
CY2013Q1 bios Medical Equipment Gross
MedicalEquipmentGross
17627000 USD
CY2012Q4 bios Medical Equipment Gross
MedicalEquipmentGross
16466000 USD
CY2013Q1 bios Number Of Customers
NumberOfCustomers
15000
CY2013Q1 bios One Time Costs Related To Pharmacy Services Asset Sale Reserve
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserve
132000 USD
CY2012Q4 bios One Time Costs Related To Pharmacy Services Asset Sale Reserve
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserve
134000 USD
CY2013Q1 bios One Time Costs Related To Pharmacy Services Asset Sale Reserve Settled In Cash
OneTimeCostsRelatedToPharmacyServicesAssetSaleReserveSettledInCash
-2000 USD
CY2013Q1 bios Senior Notes Fair Value Disclosure
SeniorNotesFairValueDisclosure
246400000 USD
CY2013Q1 bios Shelf Registration Authorized Proceeds
ShelfRegistrationAuthorizedProceeds
200000000 USD
CY2013Q1 bios Shelf Registration Selling Stockholders Additional Sellable Shares Upon Exercise Of Warrants
ShelfRegistrationSellingStockholdersAdditionalSellableSharesUponExerciseOfWarrants
3400945 shares
CY2013Q1 bios Shelf Registration Selling Stockholders Saleable Shares
ShelfRegistrationSellingStockholdersSaleableShares
12682831 shares
CY2013Q1 bios Total Purchase Price At Closing Including Value Of Inventories On Hand Attributable To Operations Subject To Pharmacy Services Asset Sale
TotalPurchasePriceAtClosingIncludingValueOfInventoriesOnHandAttributableToOperationsSubjectToPharmacyServicesAssetSale
158800000 USD
CY2013Q1 bios Transitional Expenses
TransitionalExpenses
900000 USD
CY2012Q1 bios Transitional Expenses
TransitionalExpenses
100000 USD
CY2013Q1 bios Vehicles Gross
VehiclesGross
1630000 USD
CY2012Q4 bios Vehicles Gross
VehiclesGross
1540000 USD
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001014739
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67529494 shares
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
BioScrip, Inc.

Files In Submission

Name View Source Status
0001014739-13-000004-index-headers.html Edgar Link pending
0001014739-13-000004-index.html Edgar Link pending
0001014739-13-000004.txt Edgar Link pending
0001014739-13-000004-xbrl.zip Edgar Link pending
bios-20130331.xml Edgar Link completed
bios-20130331.xsd Edgar Link pending
bios-20130331x10q.htm Edgar Link pending
bios-20130331_cal.xml Edgar Link unprocessable
bios-20130331_def.xml Edgar Link unprocessable
bios-20130331_lab.xml Edgar Link unprocessable
bios-20130331_pre.xml Edgar Link unprocessable
bios-ex101x20130331.htm Edgar Link pending
bios-ex102x20130331.htm Edgar Link pending
bios-ex311x20130331.htm Edgar Link pending
bios-ex312x20130331.htm Edgar Link pending
bios-ex321x20130331.htm Edgar Link pending
bios-ex322x20130331.htm Edgar Link pending
bioscriplogoa01a01.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending